¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.

@article{Groheux2014FFDGPETCTIS,
  title={¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.},
  author={David Groheux and Elif Hindi{\'e} and Michel M. Marty and Marc Espie and Domenico Rubello and Laetitia Vercellino and Guilhem Bousquet and Jessica Ohnona and M E Toubert and Pascal Merlet and J. L. Misset},
  journal={European journal of radiology},
  year={2014},
  volume={83 10},
  pages={1925-33}
}
PURPOSE Male breast cancer (BC) is a rare disease, with patterns different from those found in women. Most tumors are detected at more advanced stages than in women. The aim of this study was to analyze the performance of [18F]fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG-PET/CT) in staging, restaging, and therapy response assessment. METHODS We performed a systematic analysis in the database of Saint-Louis Hospital to identify male patients with BC referred… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS